Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01044160 · ClinicalTrials.gov registry record

Stress, Adjustment And Growth In Children With Cancer And Their Parents

A clinical trial of Post Traumatic Stress Disorder and Posttraumatic Growth, sponsored by St. Jude Children's Research Hospital.

Active
Registry status
663
Enrollment target
1
Study location

NCT01044160: Active study of Post Traumatic Stress Disorder and Posttraumatic Growth, sponsored by St. Jude Children's Research Hospital.

NCT01044160 is a study of Post Traumatic Stress Disorder and Posttraumatic Growth that is active but no longer recruiting, run by St. Jude Children's Research Hospital. The registered enrollment target is 663 participants, roughly in line with the 661-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01044160, a study of Post Traumatic Stress Disorder and Posttraumatic Growth, is active but no longer recruiting, sponsored by St. Jude Children's Research Hospital.

ACTIVE NOT RECRUITING
Registry status
663 participants
Enrollment target
1
Study location

Study Summary

This proposal examines trauma and growth responses in the childhood cancer experience. It addresses a number of gaps and unanswered questions in the literature, while integrating several distinct but related lines of research. The rationale for this proposal is outlined briefly as follows: 1. Traumatic stress models focused on pathology dominate pediatric psychosocial oncology research despite empiric evidence of low levels of post-traumatic stress in this population. 2. The assumption of 'cancer as a traumatic event' has biased research designs (including lack of control comparisons) to focus on deficits and pathological outcomes. 3. This deficit-oriented approach has stimulated the development of interventions to treat or prevent PTSD, which may be unnecessary or even harmful. 4. Theoretical and empiric evidence suggests that a more common response to traumatic stress is growth and positive change, but posttraumatic growth phenomenon have been understudied in pediatric populations. 5. Cognitive and personality factors are important determinants of PTSD and positive growth outcomes, and some constructs from positive psychology theory may be particularly relevant in children with cancer. 6. Empirically, parents of children with cancer appear to be at higher risk of PTSD/PTSS, although results are not unequivocal, and the same research biases have applied to parental outcomes. This proposal includes assessment of parental PTSS and PTG, both as an outcome and a predictor of child outcomes.

Study Locations (1)

Tennessee

  • St. Jude Children's Research Hospital - Memphis

Trial Details

FieldValue
Enrollment Target 663 participants
Start Date 2009-07-07
Est. Completion 2026-07-07

What the registry record for NCT01044160 still lists

NCT01044160 is an observational study that tracks outcomes without assigning an intervention. The registered 663 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 661-participant average among 262 other Post Traumatic Stress Disorder trials with a reported enrollment target.

The record links to 2 conditions, with Post Traumatic Stress Disorder appearing as the primary indexed condition, and to 0 interventions.

NCT01044160 reports a single indexed study location in Tennessee.

Frequently Asked Questions

What is clinical trial NCT01044160 about?

NCT01044160 is a clinical study titled "Stress, Adjustment And Growth In Children With Cancer And Their Parents". This proposal examines trauma and growth responses in the childhood cancer experience. It addresses a number of gaps and unanswered questions in the literature, while integrating several distinct but related lines of research. The rationale for this proposal is outlined briefly as follows: 1. Traum...

What is the current status of trial NCT01044160?

This trial is currently active not recruiting. The enrollment target is 663 participants. The study started on 2009-07-07. Estimated completion is 2026-07-07.

What conditions does trial NCT01044160 study?

This clinical trial studies the following conditions: Post Traumatic Stress Disorder, Posttraumatic Growth.

Who is sponsoring clinical trial NCT01044160?

This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01044160 being conducted?

This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Post Traumatic Stress Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01044160's enrollment target sits among peer trials

663 10th of 262 higher than 253 of 262 other Post Traumatic Stress Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Post Traumatic Stress Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT07164443 · 663 participants · Phase 3

    A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)

  • NCT06607341 · 664 participants · NA

    Community Engagement Alliance Against Disparities

  • NCT05254743 · 662 participants · Phase 3

    A Study of Pirtobrutinib (LOXO-305) Versus Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)

  • NCT04064060 · 665 participants · Phase 3

    A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Clinical Trials

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT01044160, the US trial registry maintained by the National Library of Medicine. NCT01044160 (mid enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.